Our present study demonstrated that SIGIRR deficiency contributed to memory CD4 T-cell abnormalities by facilitating the IL1/C/EBPβ/TNF-α signaling axis in rheumatoid arthritis, highlighting a novel molecular mechanism for RA development and the potential application of SIGIRR activation for RA treatment. The gene discussed is CEBPB; the disease is rheumatoid arthritis.